高科石化(002778.SZ):持股5.05%的長橋集團擬減持不超1%的股份
格隆匯 5 月 6日丨高科石化(002778.SZ)公佈,持公司股份450萬股,佔總股本的5.0500%的股東蘇州市長橋集團有限公司,計劃自公吿之日起三個工作日後的6個月內通過集中競價交易或其他合法方式減持公司股份合計不超過89.1095萬股,即不超過公司總股本的1%。
其中,通過集中競價方式減持的,將於減持計劃公吿之日起十五個交易日後進行,即從2021年5月31日起至2021年11月29日止,且任意連續九十個自然日內通過證券交易所集中競價交易減持股份的總數不超過公司總股本的1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.